Intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: preliminary results of a prospective randomized cross-over trial

被引：0
作者：
van Ballegooie, E.
Logtenberg, S. J. J.
Kleefstra, N.
Houweling, S. T.
Groenier, K. H.
Bilo, H. J. G.
机构：
[1] Langerhans, Med Res Grp, Zwolle, Netherlands
[2] Bethesda Gen Hosp, Hoogeveen, Netherlands
[3] Isala Clin, Ctr Diabet, Zwolle, Netherlands
[4] UMCG, Groningen, Netherlands
来源：
DIABETOLOGIA | 2007年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0223
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
[21]   Preliminary results from a randomized, controlled, cross-over trial of intrathecal oxytocin for neuropathic pain [J].
Eisenach, James C. ;
Curry, Regina S. ;
Houle, Timothy T. .
PAIN MEDICINE, 2023, 24 (09) :1058-1065
[22]   Limitations to subcutaneous insulin administration in type 1 diabetes [J].
Chen, JW ;
Christiansen, JS ;
Lauritzen, T .
DIABETES OBESITY & METABOLISM, 2003, 5 (04) :223-233
[23]   A Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion of Insulin Aspart Versus Insulin Lispro in Children and Adolescents With Type 1 Diabetes [J].
Weinzimer, Stuart A. ;
Ternand, Christine ;
Howard, Campbell ;
Chang, Cheng-Tao ;
Becker, Dorothy J. ;
Laffel, Lori M. B. .
DIABETES CARE, 2008, 31 (02) :210-215
[24]   Different Effects of Intraperitoneal and Subcutaneous Insulin Administration on the GH-IGF-1 Axis in Type 1 Diabetes [J].
van Dijk, Peter R. ;
Logtenberg, Susan J. J. ;
Chisalita, Simona I. ;
Hedman, Christina A. ;
Groenier, Klaas H. ;
Gans, Reinold O. B. ;
Kleefstra, Nanne ;
Arnqvist, Hans J. ;
Bilo, Henk J. G. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (06) :2493-2501
[25]   Results of a randomised controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes [J].
Deiss, D ;
Hartmann, R ;
Schmidt, J ;
Kordonouri, O .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2006, 114 (02) :63-67
[26]   Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes [J].
Logtenberg, Susan J. ;
Kleefstra, Nanne ;
Houweling, Sebastiaan T. ;
Groenier, Klaas H. ;
Gans, Reinold O. ;
Bilo, Henk J. .
DIABETES CARE, 2010, 33 (06) :1169-1172
[27]   Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial [J].
Harbo, T. ;
Andersen, H. ;
Hess, A. ;
Hansen, K. ;
Sindrup, S. H. ;
Jakobsen, J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (05) :631-638
[28]   A RANDOMIZED CROSS-OVER COST-BENEFITS COMPARISON OF INTENSIVE INSULIN THERAPY WITH INTRAPERITONEAL INFUSION VIA IMPLANTABLE PUMPS VS MULTIPLE SUBCUTANEOUS INJECTIONS IN PATIENTS WITH TYPE-I DIABETES [J].
SELAM, JL ;
HAARDT, MJ ;
SLAMA, G ;
BETHOUX, JP .
DIABETES, 1994, 43 :A167-A167
[29]   Continuous Intraperitoneal Insulin Infusion Versus Subcutaneous Insulin Therapy in the Treatment of Type 1 Diabetes: Effects on Glycemic Variability [J].
van Dijk, Peter R. ;
Groenier, Klaas H. ;
DeVries, J. Hans ;
Gans, Reinold O. B. ;
Kleefstra, Nanno ;
Bilo, Henk J. G. ;
Logtenberg, Susan J. J. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (06) :379-384
[30]   Glucose excursions and hypoglycemia in patients with type 2 diabetes treated with mitiglinide/voglibose versus glimepiride: A randomized cross-over trial [J].
Fujimoto, Kanta ;
Shibayama, Yui ;
Yamaguchi, Eriko ;
Honjo, Sachiko ;
Hamasaki, Akihiro ;
Hamamoto, Yoshiyuki .
JOURNAL OF DIABETES, 2018, 10 (08) :675-682
12345